Codelac Broncho (Ambroxol, Sodium bicarbonate) pills

Codelac Broncho (Ambroxol, Sodium bicarbonate) pills

To favorites
Codelac Broncho (Ambroxol, Sodium bicarbonate) pills combined drug for the treatment of cough, has a mucolytic and expectorant effect, and also has anti-inflammatory activity
Active substance:Ambroxol, Sodium bicarbonate, Sodium glycyrrhizinate, Thermopsis extract
Pharmacological group:Cough medicines
Country of origin:Russia
In stock
In stock

Instructions for Codelac Broncho (Ambroxol, Sodium bicarbonate) pills

English product name
Codelac Broncho

Release form

Description Codelac Broncho:

Tablets from light cream to cream with a yellowish color tint with darker and lighter embellishments, flat cylindrical, with a risk and chamfer.

1 tab.
ambroxol hydrochloride 20 mg
sodium glycyrrhizate 30 mg
dry extract of thermopsis 10 mg
sodium hydrogen carbonate 200 mg
Auxiliary substances: potato starch,
cellulose microcrystalline,
povidone K25 (collydon K25),
talc, stearic acid,
sodium carboxymethyl starch (sodium starch glycolate, primogel).

10 pcs - packages of box contour (1) - cardboard packs.
10 pcs - packages of box contour (2) - cardboard packs.

ATC codes
R05CA10 Combination drugs

Clinical-pharmacological groups / Group affiliation
Preparation with mucolytic, expectorant and anti-inflammatory action

Active substance
ambroxol hydrochloride
sodium hydrogen carbonate
sodium glycyrrhizate
dry extract of thermopsis

Pharmacotherapy group Codelac Broncho:

Expectorant combined agent

Storage Conditions
The drug should be stored in a place inaccessible to children, protected from light at a temperature not higher than 25 ° C.

Best before date
The shelf life is two years.

Testimony Codelac Broncho:

  • Respiratory tract diseases with sputum withdrawal difficulty:
  • acute and chronic bronchitis;
  • pneumonia;
  • COPD;
  • bronchiectasis.

Method of use, course and dosage:

The drug should be taken orally during meals.
Adults and children over the age of twelve are given one tablet three times a day
It is not recommended to use the drug for more than four to five days

Use in children
Contraindication: Children under twelve years of age.

  • Nosology (ICD codes)
  • J15
  • Bacterial pneumonia not classified elsewhere
  • J20
  • Acute bronchitis
  • J42
  • Chronic bronchitis unspecified
  • J44
  • Other chronic obstructive pulmonary disease
  • J47
  • Bronchiectasis

pharmachologic effect:

The combined preparation for treating cough has a mucolytic and expectorant effect and also has anti-inflammatory activity. The action of Kodelak® Bronho is due to the pharmacological properties of its components.

Ambroxol has a secretomotor, secretolytic and expectorant effect, normalizes the broken ratio of sulfur and mucous components of sputum, increases surfactant secretion in the alveoli. Reduces the viscosity of the sputum and promotes its withdrawal.

Active substance
Pharmacological group
Country of origin
Expiration Date
No reviews yet — your comment may be first.
All reviews 0
general rating